Rickettsial infections such as Scrub Typhus (ST), Spotted Fever (SF), Murine Typhus (MT) and Q Fever (QF) has recently emerged as one of the major public health issues globally. Scrub typhus is the most common of all the rickettsial infections and there has been a re-emergence in the last two decades are often being under diagnosed in the country. Scrub typhus, which was previously reported only in the tsutsugamushi triangle (Asia-Pacific rim), has been identified in other countries such as Dubai and Chile. It is estimated that over 2 billion people are at risk and more than 1million cases occur each year in the tsutsugamushi triangle.

In CMC, Vellore, 36% of the AUFI cases are scrub typhus followed by dengue and malaria. The symptoms of this infection may vary from having a low grade fever to severe multi-organ dysfunction syndrome (MODS) if untreated. Mortality among untreated cases is quite high, up to 70% depending on the severity of the disease. Spotted fever is next to the scrub typhus in terms of prevalence among other rickettsial infections and commonly seen in children. It presents as fever with rash which makes it very difficult to distinguish from other causes of exanthematous fevers. The other rickettsial infections such as Murine Typhus and Q Fever are less common. Doxycycline and azithromycin have proved to be very effective in treating all rickettsial infections and controlling the illness.

Therefore, the main challenge is in disease diagnosis, which is depended not only on lab expertise, but also clinical suspicion followed by a thorough clinical examination. As many institutes or hospitals or medical colleges lack of resources (expertise, equipment and reagent), they are unable to diagnose rickettsial infections effectively and in a timely manner.

01

Rationale/ gaps in existing knowledge

  • Few laboratories diagnose rickettsioses with no National reference laboratory (NRL) and no EQAS provider available in India. Genomic data is insufficient and many biological characteristics of rickettsial pathogens are not known. There is paucity of data on burden of rickettsioses amongst cases of febrile illness. This is related to the lack of diagnostic capacity.
02

Novelty

  • Establishment of NRCRD which will evaluate newer diagnostics, provide a robust EQAS, train personnel, generate genomic data, enhance our understanding of pathogen biology and implement hospital based rickettsial surveillance, risk prediction and health education modules for prevention and control.
03

Objectives

  • To develop and assess fit for purpose diagnostics for rickettsioses
  • To study the biological characteristics of Indian rickettsial agents
  • To provide training in Rickettsial disease diagnosis and establish robust quality assurance support for rickettsioses
  • To implement strategies for National Rickettsial Surveillance
04

Methods

  • Available assays (Molecular, serological & POCT) and those with “proof of concept” will be evaluated prospectively to determine best assays for field and laboratory use. Using cell culture isolates, the pathophysiology, genomics and cytokine profiles of Indian rickettsial isolates will be assessed. Genomic data will be generated and analysed. Using existing and prospective data, surveillance strategies and prediction models will be developed, complemented by health education for prevention. Training modules for serological and molecular diagnosis of rickettsioses will be generated and workshops conducted. An EQAS covering serological and molecular assays will be established and provided to all stakeholders/participants.
  • Expected outcome:
  • Information on most effective assay for serological and molecular diagnosis for different resource levels. Knowledge of biology of Indian rickettsial agents including genomic data. Availability of rickettsial diagnostic facilities capable of providing rapid and accurate results. Establishment of rickettsial surveillance will provide disease burden data which can be used
  • for risk prediction using artificial intelligence and health education module development for prevention and control.

Dr. John Antony Jude Prakash

Senior Professor & Head,

Department of Clinical Microbiology

PI - Information

  • Microbiologist (25 years experience) with special interest in bacterial zoonoses, one health and diagnostic immunology
  • Member of ASTMH, ESA (Entomological Society of America) and life member IAMM
  • Host professor: ASM (American Society of Microbiology) 2013
  • Visiting Scientist: Sept 2011 to Sept 2012: NMRC, Silver Spring, MD, USA
  • PI designate: Centre for Advanced Research, ICMR for Rickettsial diseases
  • Publications: 120 (International: 83, National: 37)
  • Special Interests:
  • Bacterial zoonoses: One Health
  • Diseases of interest: Rickettsial infections, Anthrax, Leptospirosis, Melioidosis and Brucellosis especially epidemiology, biology including diagnostics